Skip to content

Interferon beta-1a

Avonex, Rebif (interferon beta-1a) is a protein pharmaceutical. Interferon beta-1a was first approved as Avonex on 1996-05-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.
Trade Name Avonex, Rebif
Common Name Interferon beta-1a
Indication multiple sclerosis
Drug Class
Interferon beta-1a
Get full access now